Ergoteles LLC Bridge Bio Pharma, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $61,077 - $104,394	-9,062 Reduced 29.24%	21,932 $167,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $246,092 - $383,085	30,994 New	30,994 $308,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $1.21 Million - $5.69 Million	-106,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $5 Million - $6.85 Million	106,600 New	106,600 $5 Million
Q1 2021 May 12, 2021	SELL	$55.47 - $72.35 $1.97 Million - $2.58 Million	-35,600 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$38.38 - $71.11 $1.12 Million - $2.08 Million	29,200 Added 456.25%	35,600 $2.53 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $174,080 - $270,016	6,400 New	6,400 $240,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.